Not applicableStudy completedNCT04740320What this trial is testingCOVID-19 SARS-CoV-2 Screening ProtocolWho this might be right forCovid19 Imperial College London 36
Early research (Phase 1)Study completedNCT04839146What this trial is testingSafety and Tolerability of COVID-19 Vaccine (ABNCoV2)Who this might be right forCovid19Severe Acute Respiratory SyndromeSARS-CoV-2 Infection Radboud University Medical Center 45
Not applicableStudy completedNCT04719182What this trial is testingPractice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19Who this might be right forCovid19PneumoniaThrombosis+3 more Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,011
Early research (Phase 1)Study completedNCT04839042What this trial is testingA Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy VolunteersWho this might be right forCovid19 Moat Biotechnology Corporation 196
Early research (Phase 1)Study completedNCT04737486What this trial is testingA First-in-Human Study of AV-001 in Healthy SubjectsWho this might be right forCovid19-associated ARDSCovid19ARDS Vasomune Therapeutics, Inc. 48
Large-scale testing (Phase 3)Study completedNCT04724629What this trial is testingSurvival TRial Using CytoKines in COVID-19 (STRUCK Trial)Who this might be right forCovid19 University of Sao Paulo 60
Not applicableUnknownNCT04503057What this trial is testingExhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS)Who this might be right forCovid19ARDS, HumanALI Lund University Hospital 300
Early research (Phase 1)Ended earlyNCT04659122What this trial is testingA Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired PneumoniaWho this might be right forCOVID-19Undefined Airway Therapeutics, Inc. 5
Testing effectiveness (Phase 2)Ended earlyNCT04390503What this trial is testingConvalescent Plasma for Early Treatment of COVID-19Who this might be right forSARS-CoV 2COVID-19 Andrew Eisenberger 223
Testing effectiveness (Phase 2)UnknownNCT04646603What this trial is testingMRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 PatientsWho this might be right forCOVID-19ARDS, HumanStem Cells+1 more MedRegen LLC 40
Testing effectiveness (Phase 2)Study completedNCT04335136What this trial is testingRecombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19Who this might be right forCOVID-19 Apeiron Biologics 185
Early research (Phase 1)UnknownNCT04864548What this trial is testingCOV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection StudyWho this might be right forCoronavirus University of Oxford 132
Post-approval studies (Phase 4)Ended earlyNCT04397510What this trial is testingNebulized Heparin for the Treatment of COVID-19 Induced Lung InjuryWho this might be right forCovid-19ARDS, HumanAcute Lung Injury Frederick Health 13
Not applicableStudy completedNCT05033782What this trial is testingImpact of the Modifications of Environmental Exposures and Health Care Access During COVID-19 Lockdown on Multiple SclerosisWho this might be right forMultiple Sclerosis Assistance Publique - Hôpitaux de Paris 1,209
Not applicableEnded earlyNCT04725097What this trial is testingEvaluate Rapid Throughput Screening for Human COVID-19 InfectionWho this might be right forCovid19 Mayo Clinic 2,821
Testing effectiveness (Phase 2)WithdrawnNCT04377568What this trial is testingEfficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized ChildrenWho this might be right forHospitalized ChildrenCovid-19 Infection The Hospital for Sick Children
Not applicableActive Not RecruitingNCT06640387What this trial is testingCARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and SchoolsWho this might be right forSARS CoV 2 InfectionRSV InfectionInfluenza+2 more The Hospital for Sick Children 500
Large-scale testing (Phase 3)UnknownNCT04320238What this trial is testingExperimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical StaffWho this might be right for2019 Novel Coronavirus Infection Shanghai Jiao Tong University School of Medicine 2,944
Not applicableStudy completedNCT05866237What this trial is testingCOVID-19 Vaccine Uptake Amongst Underserved Populations in East LondonWho this might be right forCOVID-19InfluenzaVaccination Refusal Queen Mary University of London 5,903
Early research (Phase 1)Study completedNCT06026514What this trial is testingPhase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in AdultsWho this might be right forSARS-CoV-2 Infection National Institute of Allergy and Infectious Diseases (NIAID) 27